{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:32:34Z","timestamp":1793230354965,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.critrevonc.2026.105645","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T15:11:29Z","timestamp":1791558689000},"page":"105645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Circular RNAs in breast cancer immunometabolism: Mechanisms of immune regulation and metabolic reprogramming"],"prefix":"10.1016","volume":"228","author":[{"given":"Hailiang","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianing","family":"Jian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.critrevonc.2026.105645_bib1","series-title":"Nano Drug Delivery for Cancer Therapy: Principles and Practices","article-title":"Future trends and innovation in nano drug delivery for cancer therapy, application of siRNA (nanoparticle-based RNA) therapy, ultrasound linked nano-cancer therapeutics, and application of exosomes-based cancer therapy","author":"Abbasi","year":"2024"},{"key":"10.1016\/j.critrevonc.2026.105645_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113797","article-title":"Natural products targeting the ATR-CHK1 signaling pathway in cancer therapy","volume":"155","author":"Ahmed","year":"2022","journal-title":"' Biomed. & Pharmacother."},{"key":"10.1016\/j.critrevonc.2026.105645_bib3","doi-asserted-by":"crossref","first-page":"8139","DOI":"10.1007\/s00210-025-03901-w","article-title":"Marine peptides in lymphoma: surgery at molecular level for therapeutic understanding'","volume":"398","author":"Ahmed","year":"2025","journal-title":"Naunyn-Schmiede 's. Arch. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib4","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.55730\/1300-0144.6061","article-title":"'Unveiling the potential of marine peptides in leukemia: mechanistic insights and future horizon in peptide research'","volume":"55","author":"Ahmed","year":"2025","journal-title":"Turk. J. Med. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96262-2","article-title":"Monocyte-derived and M1 macrophages from ankylosing spondylitis patients released higher TNF-\u03b1 and expressed more IL1B in response to BzATP than macrophages from healthy subjects","volume":"11","author":"Akhtari","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.critrevonc.2026.105645_bib6","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.3390\/ijms24032606","article-title":"Modulating glycolysis to improve cancer therapy","volume":"24","author":"Chelakkot","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib7","first-page":"777","article-title":"Circular RNA AGFG1 motivates breast cancer cell proliferation, invasion, migration, and glycolysis by controlling microRNA-653-5p\/14-3-3 protein epsilon","volume":"70","author":"Chen","year":"2023","journal-title":"Acta Biochim. Pol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib8","article-title":"CircWHSC1 promotes breast cancer progression by regulating the FASN\/AMPK\/mTOR axis through sponging miR-195-5p","volume":"11","author":"Chen","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib9","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s42255-022-00732-4","article-title":"AMPK-dependent phosphorylation of the GATOR2 component WDR24 suppresses glucose-mediated mTORC1 activation","volume":"5","author":"Dai","year":"2023","journal-title":"Nat. Metab."},{"key":"10.1016\/j.critrevonc.2026.105645_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1723383","article-title":"From immune suppression to immunotherapy sensitization: the dual roles of circRNAs in cancer progression","volume":"16","author":"Dai","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005461","article-title":"circ-0000512 inhibits PD-L1 ubiquitination through sponging miR-622\/CMTM6 axis to promote triple-negative breast cancer and immune escape","volume":"11","author":"Dong","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105645_bib12","doi-asserted-by":"crossref","first-page":"3305","DOI":"10.3390\/cancers14143305","article-title":"Targeted therapeutic options and future perspectives for HER2-positive breast cancer","volume":"14","author":"Ferrando-D\u00edez","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.critrevonc.2026.105645_bib13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrclinonc.2017.101","article-title":"The immune contexture in cancer prognosis and treatment","volume":"14","author":"Fridman","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib14","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41392-021-00865-0","article-title":"Nuclear genome-derived circular RNA circPUM1 localizes in mitochondria and regulates oxidative phosphorylation in esophageal squamous cell carcinoma","volume":"7","author":"Gong","year":"2022","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105645_bib15","series-title":"Fundamentals of bacterial physiology and metabolism","article-title":"Glycolysis and gluconeogenesis","author":"Gupta","year":"2021"},{"key":"10.1016\/j.critrevonc.2026.105645_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/17501911.2026.2642583","article-title":"Non-coding RNAs regulation in breast cancer pathogenesis","volume":"18","author":"Gur Dedeoglu","year":"2026","journal-title":"Epigenomics"},{"key":"10.1016\/j.critrevonc.2026.105645_bib17","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/s12026-021-09237-w","article-title":"Circular RNA hsa_circ_0001598 promotes programmed death-ligand-1-mediated immune escape and trastuzumab resistance via sponging miR-1184 in breast cancer cells","volume":"69","author":"Huang","year":"2021","journal-title":"Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105645_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121745","article-title":"EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647\/FASN axis","volume":"324","author":"Huang","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1251643","article-title":"Targeting glutamine metabolic reprogramming of SLC7A5 enhances the efficacy of anti-PD-1 in triple-negative breast cancer","volume":"14","author":"Huang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00609-20","article-title":"Circular RNA circ-ERBB2 elevates the warburg effect and facilitates triple-negative breast cancer growth by the microRNA 136-5p\/pyruvate dehydrogenase kinase 4 axis","volume":"41","author":"Huang","year":"2021","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib21","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1016\/j.cmet.2021.08.006","article-title":"Exosomes as mediators of intercellular crosstalk in metabolism","volume":"33","author":"Isaac","year":"2021","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105645_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.595156","article-title":"Regulation of circular RNA CircNFATC3 in cancer cells alters proliferation, migration, and oxidative phosphorylation","volume":"9","author":"Karedath","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12885-019-5723-0","article-title":"Silencing of ANKRD12 circRNA induces molecular and functional changes associated with invasive phenotypes","volume":"19","author":"Karedath","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/j.critrevonc.2026.105645_bib24","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41571-021-00585-y","article-title":"The emerging roles of circRNAs in cancer and oncology","volume":"19","author":"Kristensen","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib25","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/s12276-024-01177-3","article-title":"Inverted Alu repeats: friends or foes in the human transcriptome","volume":"56","author":"Lee","year":"2024","journal-title":"Exp. & Mol. Med."},{"key":"10.1016\/j.critrevonc.2026.105645_bib26","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13062-023-00397-3","article-title":"Circular RNA hsa_circ_0067842 facilitates tumor metastasis and immune escape in breast cancer through HuR\/CMTM6\/PD-L1 axis","volume":"18","author":"Li","year":"2023","journal-title":"Biol. Direct"},{"key":"10.1016\/j.critrevonc.2026.105645_bib27","doi-asserted-by":"crossref","first-page":"362","DOI":"10.3390\/cells15040362","article-title":"Targeting glycolytic metabolism in cancer therapy: current approaches and future perspectives","volume":"15","author":"Li","year":"2026","journal-title":"Cells"},{"key":"10.1016\/j.critrevonc.2026.105645_bib28","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12964-023-01449-x","article-title":"Glutamine addiction in tumor cell: oncogene regulation and clinical treatment","volume":"22","author":"Li","year":"2024","journal-title":"Cell. Commun. Signal."},{"key":"10.1016\/j.critrevonc.2026.105645_bib29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s12943-024-02019-6","article-title":"CircTRIM1 encodes TRIM1-269aa to promote chemoresistance and metastasis of TNBC via enhancing CaM-dependent MARCKS translocation and PI3K\/AKT\/mTOR activation","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105645_bib30","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.18632\/aging.202415","article-title":"Hsa_circ_0000199 facilitates chemo-tolerance of triple-negative breast cancer by interfering with miR-206\/613-led PI3K\/Akt\/mTOR signaling","volume":"13","author":"Li","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.critrevonc.2026.105645_bib31","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s00018-015-2070-4","article-title":"Reprogramming of glucose, fatty acid and amino acid metabolism for cancer progression","volume":"73","author":"Li","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib32","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12943-024-02037-4","article-title":"Exosomal circSIPA1L3-mediated intercellular communication contributes to glucose metabolic reprogramming and progression of triple negative breast cancer","volume":"23","author":"Liang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105645_bib33","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.canlet.2021.04.023","article-title":"Targeting lipid metabolism is an emerging strategy to enhance the efficacy of anti-HER2 therapies in HER2-positive breast cancer","volume":"511","author":"Ligorio","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105645_bib34","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1016\/j.cell.2022.04.021","article-title":"Circular RNAs: characterization, cellular roles, and applications","volume":"185","author":"Liu","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.critrevonc.2026.105645_bib35","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00432-024-05736-z","article-title":"CircCOL1A1 promotes proliferation, migration, and invasion of colorectal cancer (CRC) cells and glutamine metabolism through GLS1 up-regulation by sponging miR-214-3p","volume":"150","author":"Liu","year":"2024","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib36","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3389\/fgene.2020.00193","article-title":"circGNB1 facilitates triple-negative breast cancer progression by regulating miR-141-5p-IGF1R axis","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Genet."},{"key":"10.1016\/j.critrevonc.2026.105645_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106098","article-title":"Endoplasmic reticulum stress promotes breast cancer cells to release exosomes circ_0001142 and induces M2 polarization of macrophages to regulate tumor progression","volume":"177","author":"Lu","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.critrevonc.2026.105645_bib38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/13543784.2022.2067527","article-title":"PARP inhibitors as single agents and in combination therapy: the most promising treatment strategies in clinical trials for BRCA-mutant ovarian and triple-negative breast cancers","volume":"31","author":"Luo","year":"2022","journal-title":"Expert. Opin. Investig. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105645_bib39","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1080\/15384101.2022.2071565","article-title":"CircRNA OXCT1 promotes the malignant progression and glutamine metabolism of non-small cell lung cancer by absorbing miR-516b-5p and upregulating SLC1A5","volume":"22","author":"Luo","year":"2023","journal-title":"Cell. Cycle"},{"key":"10.1016\/j.critrevonc.2026.105645_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcp.2022.101829","article-title":"Circ_0039960 regulates growth and Warburg effect of breast cancer cells via modulating miR-1178\/PRMT7 axis","volume":"64","author":"Ma","year":"2022","journal-title":"Mol. Cell. Probes"},{"key":"10.1016\/j.critrevonc.2026.105645_bib41","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/s41419-024-06698-3","article-title":"The role of circular RNAs in regulating resistance to cancer immunotherapy: mechanisms and implications","volume":"15","author":"Ma","year":"2024","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.critrevonc.2026.105645_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/ijms252313056","article-title":"CircRNAs and miRNAs: key player duo in breast cancer dynamics and biomarkers for breast cancer early detection and prevention","volume":"25","author":"Maatouk","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib43","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/10932607251325751","article-title":"'Bispecific antibodies (bsAbs) directed against PD-1\/PD-L1 and CTLA-4; a mini review'","volume":"33","author":"Mardi","year":"2025","journal-title":"Hum. Antibodies"},{"key":"10.1016\/j.critrevonc.2026.105645_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1305","article-title":"Type 1 conventional dendritic cells and interferons are required for spontaneous CD4(+) and CD8(+) T-cell protective responses to breast cancer","volume":"10","author":"Mattiuz","year":"2021","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib45","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s12943-019-1022-2","article-title":"Targeting Tyro3, Axl and MerTK (TAM receptors): implications for macrophages in the tumor microenvironment","volume":"18","author":"Myers","year":"2019","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.critrevonc.2026.105645_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202002232","article-title":"A novel long non-coding RNA lnc030 maintains breast cancer stem cell stemness by stabilizing SQLE mRNA and Increasing Cholesterol Synthesis","volume":"8","author":"Qin","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2026.105214","article-title":"Targeting lncRNA-mediated networks to overcome doxorubicin resistance in cancer","author":"Qiu","year":"2026","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib48","doi-asserted-by":"crossref","first-page":"8934","DOI":"10.3390\/ijms25168934","article-title":"Nanoparticles-delivered circular RNA strategy as a novel antitumor approach","volume":"25","author":"Racca","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib49","doi-asserted-by":"crossref","DOI":"10.2147\/IJN.S559584","article-title":"Enhancing the safety of nanoparticles in medicine: highlights of progress and critical objectives","author":"Ramos","year":"2026","journal-title":"Int. J. Nanomed. 559584."},{"key":"10.1016\/j.critrevonc.2026.105645_bib50","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s11658-023-00447-8","article-title":"The role of noncoding RNAs in metabolic reprogramming of cancer cells","volume":"28","author":"Safi","year":"2023","journal-title":"Cell. Mol. Biol. Lett."},{"key":"10.1016\/j.critrevonc.2026.105645_bib51","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1513421","article-title":"Patterns of immune evasion in triple-negative breast cancer and new potential therapeutic targets: a review","volume":"15","author":"Serrano Garc\u00eda","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib52","doi-asserted-by":"crossref","first-page":"7607","DOI":"10.7150\/thno.116250","article-title":"Metabolic targeting of oxidative phosphorylation enhances chemosensitivity in triple-negative breast cancer via a synergistic nanomedicine","volume":"15","author":"Shen","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.critrevonc.2026.105645_bib53","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41698-024-00507-y","article-title":"Exosomal circRHCG promotes breast cancer metastasis via facilitating M2 polarization through TFEB ubiquitination and degradation","volume":"8","author":"Shen","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib54","doi-asserted-by":"crossref","first-page":"726","DOI":"10.3390\/ijms26020726","article-title":"Circular RNA formation and degradation are not directed by universal pathways","volume":"26","author":"Srinivasan","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib55","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1042\/CS20220531","article-title":"M1\/M2 macrophages and their overlaps\u2013myth or reality?'","volume":"137","author":"Strizova","year":"2023","journal-title":"Clin. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib56","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2147\/OTT.S289241","article-title":"Circular RNA circDNM3OS functions as a miR-145-5p sponge to accelerate cholangiocarcinoma growth and glutamine metabolism by upregulating MORC2","author":"Su","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.critrevonc.2026.105645_bib57","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1097\/CAD.0000000000001076","article-title":"Hsa_circ_0069094 knockdown inhibits cell proliferation, migration, invasion and glycolysis, while induces cell apoptosis by miR-661\/HMGA1 axis in breast cancer","volume":"32","author":"Sui","year":"2021","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105645_bib58","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.tem.2022.07.005","article-title":"Location matters: hexokinase 1 in glucose metabolism and inflammation","volume":"33","author":"Sundaram","year":"2022","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.critrevonc.2026.105645_bib59","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ccell.2018.03.012","article-title":"T cell dysfunction in cancer","volume":"33","author":"Thommen","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.critrevonc.2026.105645_bib60","article-title":"Adaptive drug resistance mechanisms driven by non-coding RNA\u2013protein interaction networks in hepatocellular carcinoma","author":"Tian","year":"2025","journal-title":"Crit. Rev. Oncol. \/Hematol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib61","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.omtn.2021.06.017","article-title":"Circular RNA: a potential diagnostic, prognostic, and therapeutic biomarker for human triple-negative breast cancer'","volume":"26","author":"Tian","year":"2021","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.critrevonc.2026.105645_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1400744","article-title":"Exploring non-coding RNA mechanisms in hepatocellular carcinoma: implications for therapy and prognosis","volume":"15","author":"Tian","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib63","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.critrevonc.2026.105645_bib64","article-title":"Circular RNAs as biomarkers and targets in ovarian cancer","author":"Visht","year":"2025","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.critrevonc.2026.105645_bib65","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/imm.13520","article-title":"Human FOXP3 and tumour microenvironment","volume":"168","author":"Wang","year":"2023","journal-title":"Immunology"},{"key":"10.1016\/j.critrevonc.2026.105645_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/s41392-024-01779-3","article-title":"Progression from ductal carcinoma in situ to invasive breast cancer: molecular features and clinical significance","volume":"9","author":"Wang","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2026.105645_bib67","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10863-023-09985-4","article-title":"Hsa_circ_0052611 and mir-767-5p guide the warburg effect, migration, and invasion of BRCA cells through modulating SCAI","volume":"55","author":"Wang","year":"2023","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.critrevonc.2026.105645_bib68","doi-asserted-by":"crossref","first-page":"6560","DOI":"10.3390\/ijms22126560","article-title":"'The impact of the tumor microenvironment on macrophage polarization in cancer metastatic progression","volume":"22","author":"Wang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1158\/2326-6066.CIR-22-0410","article-title":"Extracellular vesicle\u2013packaged circATP2B4 mediates M2 macrophage polarization via miR-532-3p\/SREBF1 axis to promote epithelial ovarian cancer metastasis","volume":"11","author":"Wang","year":"2023","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.critrevonc.2026.105645_bib70","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/tox.23509","article-title":"A novel circular RNA confers trastuzumab resistance in human epidermal growth factor receptor 2-positive breast cancer through regulating ferroptosis","volume":"37","author":"Wang","year":"2022","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12672-023-00679-2","article-title":"Myc derived circRNA promotes triple-negative breast cancer progression via reprogramming fatty acid metabolism","volume":"14","author":"Wang","year":"2023","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib72","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2147\/BCTT.S432526","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","author":"Wang","year":"2023","journal-title":"Breast Cancer Targets Therapy"},{"key":"10.1016\/j.critrevonc.2026.105645_bib73","doi-asserted-by":"crossref","first-page":"10624","DOI":"10.1080\/21655979.2021.2000731","article-title":"Knockdown of circular RNA septin 9 inhibits the malignant progression of breast cancer by reducing the expression of solute carrier family 1 member 5 in a microRNA-149-5p-dependent manner","volume":"12","author":"Wang","year":"2021","journal-title":"Bioengineered"},{"key":"10.1016\/j.critrevonc.2026.105645_bib74","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1080\/21655979.2022.2036894","article-title":"Circular RNA UBAP2 facilitates the cisplatin resistance of triple-negative breast cancer via microRNA-300\/anti-silencing function 1B histone chaperone\/PI3K\/AKT\/mTOR axis","volume":"13","author":"Wang","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.critrevonc.2026.105645_bib75","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nature14405","article-title":"Structures of human phosphofructokinase-1 and atomic basis of cancer-associated mutations","volume":"523","author":"Webb","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.critrevonc.2026.105645_bib76","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tibs.2010.05.003","article-title":"Glutamine addiction: a new therapeutic target in cancer","volume":"35","author":"Wise","year":"2010","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.critrevonc.2026.105645_bib77","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.canlet.2014.01.031","article-title":"PKM2 contributes to cancer metabolism","volume":"356","author":"Wong","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.critrevonc.2026.105645_bib78","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12944-024-02024-0","article-title":"Reprogramming of lipid metabolism in the tumor microenvironment: a strategy for tumor immunotherapy","volume":"23","author":"Wu","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.critrevonc.2026.105645_bib79","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.cmet.2023.07.006","article-title":"Emerging therapies in cancer metabolism","volume":"35","author":"Xiao","year":"2023","journal-title":"Cell. Metab."},{"key":"10.1016\/j.critrevonc.2026.105645_bib80","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41420-021-00604-y","article-title":"CircRNA circ-PDCD11 promotes triple-negative breast cancer progression via enhancing aerobic glycolysis","volume":"7","author":"Xing","year":"2021","journal-title":"Cell. death Discov."},{"key":"10.1016\/j.critrevonc.2026.105645_bib81","first-page":"560","article-title":"RNA interference technology","author":"Xu","year":"2019","journal-title":"Compr. Biotechnol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e37192","article-title":"Shaping the immune landscape: Multidimensional environmental stimuli refine macrophage polarization and foster revolutionary approaches in tissue regeneration","volume":"10","author":"Xue","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.critrevonc.2026.105645_bib83","doi-asserted-by":"crossref","first-page":"15553","DOI":"10.1002\/jcb.28822","article-title":"Circular RNA circ_0103552 forecasts dismal prognosis and promotes breast cancer cell proliferation and invasion by sponging miR-1236","volume":"120","author":"Yang","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.critrevonc.2026.105645_bib84","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/s41419-021-03680-1","article-title":"Tumor-derived exosomal circPSMA1 facilitates the tumorigenesis, metastasis, and migration in triple-negative breast cancer (TNBC) through miR-637\/Akt1\/\u03b2-catenin (cyclin D1) axis","volume":"12","author":"Yang","year":"2021","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.critrevonc.2026.105645_bib85","first-page":"755","article-title":"Hsa_Circ_002144 promotes glycolysis and immune escape of breast cancer through miR-326\/PKM Axis","volume":"39","author":"Yang","year":"2024","journal-title":"Cancer Biother Radiopharm."},{"key":"10.1016\/j.critrevonc.2026.105645_bib86","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.ymthe.2021.03.003","article-title":"'Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers'","volume":"29","author":"Yu","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.critrevonc.2026.105645_bib87","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/CAD.0000000000001264","article-title":"Knockdown of circ_0102273 inhibits the proliferation, metastasis and glycolysis of breast cancer through miR-1236-3p\/PFKFB3 axis","volume":"33","author":"Yu","year":"2022","journal-title":"Anticancer. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105645_bib88","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41419-022-05540-y","article-title":"CircRNA MBOAT2 promotes intrahepatic cholangiocarcinoma progression and lipid metabolism reprogramming by stabilizing PTBP1 to facilitate FASN mRNA cytoplasmic export","volume":"14","author":"Yu","year":"2023","journal-title":"Cell. Death & Dis."},{"key":"10.1016\/j.critrevonc.2026.105645_bib89","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1007\/s00404-022-06481-9","article-title":"Circ_0062558 promotes growth, migration, and glutamine metabolism in triple-negative breast cancer by targeting the miR-876-3p\/SLC1A5 axis","volume":"306","author":"Yuan","year":"2022","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.critrevonc.2026.105645_bib90","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12958-022-00998-z","article-title":"Circ-CSNK1G1 promotes cell proliferation, migration, invasion and glycolysis metabolism during triple-negative breast cancer progression by modulating the miR-28-5p\/LDHA pathway","volume":"20","author":"Zan","year":"2022","journal-title":"Reprod. Biol. Endocrinol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib91","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12935-025-03809-8","article-title":"Emerging roles of non-coding RNA derived from extracellular vesicles in regulating PD-1\/PD-L1 pathway: insights into cancer immunotherapy and clinical applications","volume":"25","author":"Zhang","year":"2025","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105645_bib92","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00262-024-03705-6","article-title":"circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3\/m6A\/PD-L1 manner'","volume":"73","author":"Zhang","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.critrevonc.2026.105645_bib93","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2147\/CMAR.S289172","article-title":"CircRNA circYY1 (hsa_circ_0101187) modulates cell glycolysis and malignancy through regulating YY1 expression by sponging miR-769-3p in breast cancer","author":"Zhang","year":"2021","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.critrevonc.2026.105645_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2020.145113","article-title":"Circular RNA Circ_0000442 acts as a sponge of MiR-148b-3p to suppress breast cancer via PTEN\/PI3K\/Akt signaling pathway","volume":"766","author":"Zhang","year":"2021","journal-title":"Gene"},{"key":"10.1016\/j.critrevonc.2026.105645_bib95","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/cbr.2019.3389","article-title":"Circle RNA circABCB10 modulates PFN2 to promote breast cancer progression, as well as aggravate radioresistance through facilitating glycolytic metabolism via miR-223-3p","volume":"36","author":"Zhao","year":"2021","journal-title":"Cancer Biotherapy Radiopharm."},{"key":"10.1016\/j.critrevonc.2026.105645_bib96","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12935-022-02686-9","article-title":"Circular RNA circWWC3 augments breast cancer progression through promoting M2 macrophage polarization and tumor immune escape via regulating the expression and secretion of IL-4","volume":"22","author":"Zheng","year":"2022","journal-title":"Cancer Cell. Int."},{"key":"10.1016\/j.critrevonc.2026.105645_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.176221","article-title":"circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis","volume":"963","author":"Zhong","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.critrevonc.2026.105645_bib98","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13046-023-02620-5","article-title":"Targeting tumor exosomal circular RNA cSERPINE2 suppresses breast cancer progression by modulating MALT1-NF-?B-IL-6 axis of tumor-associated macrophages","volume":"42","author":"Zhou","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105645_bib99","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1763","article-title":"Exosomal circ-0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7\/NRF2 axis","volume":"14","author":"Zhuang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.critrevonc.2026.105645_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1763","article-title":"Exosomal circ-0100519 promotes breast cancer progression via inducing M2 macrophage polarisation by USP7\/NRF2 axis","volume":"14","author":"Zhuang","year":"2024","journal-title":"Clin. Transl. Med."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842826005329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T22:41:23Z","timestamp":1793227283000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842826005329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":100,"alternative-id":["S1040842826005329"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105645","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circular RNAs in breast cancer immunometabolism: Mechanisms of immune regulation and metabolic reprogramming","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105645"}}